StockData
Rallybio Corp logo

Rallybio Corp (RLYB) stock

RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.26−0.03 (-0.20%)

Close on Nov 18, 2026Market cap $82.16MP/E 3.3Yield –

Rallybio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Rallybio's price to sales ratio was 129.8× on Nov 11, 2026, against 40.5× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026129.8×+87.1
2025Dec 31, 202542.7×–

More Rallybio figures

See a number that looks wrong?